XML 28 R19.htm IDEA: XBRL DOCUMENT
v3.25.0.1

Stock-Based Compensation (Tables) | 6 Months Ended | 12 Months Ended
--- | --- | ---
Dec. 31, 2024 | Jun. 30, 2024
Stock-Based Compensation [Abstract] |  |
Schedule of Restricted Stock Awards | The following is a schedule summarizing restricted stock awards for the periods indicated:
|  | December 31, 2024 |
|  | Three Months Ended |  |  | Six Months Ended |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value per Price |  |  | Number of Shares |  |  | Weighted Average Grant Date Fair Value per Price |
Beginning balance |  |  | 6,923 |  |  | $ | 1.90 |  |  |  | 10,597 |  |  | $ | 1.90 |
Issued |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Vested |  |  | (3,674 | ) |  |  | 1.90 |  |  |  | (7,348 | ) |  |  | 1.90 |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Ending balance |  |  | 3,249 |  |  | $ | 1.90 |  |  |  | 3,249 |  |  | $ | 1.90 |
|  | December 31, 2023 |
|  | Three Months Ended |  |  | Six Months Ended |
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value per Price |  |  | Number of Shares |  |  | Weighted Average Grant Date Fair Value per Price |
Beginning balance |  |  | 21,619 |  |  | $ | 1.90 |  |  |  | 75,293 |  |  | $ | 1.97 |
Issued |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Vested |  |  | (3,675 | ) |  |  | 1.90 |  |  |  | (57,349 | ) |  |  | 1.99 |
Forfeited |  |  | - |  |  |  | - |  |  |  | - |  |  |  | - |
Ending balance |  |  | 17,944 |  |  | $ | 1.90 |  |  |  | 17,944 |  |  | $ | 1.90 |
| The following is a schedule summarizing restricted stock awards for the periods indicated:
|  | Number of Shares |  |  | Weighted Average Grant Date Fair Value Per Share |
Outstanding at July 1, 2022 |  |  | 344,426 |  |  | $ | 1.90 |
Granted |  |  | 150,000 |  |  |  | 2.00 |
Vested |  |  | (419,133 | ) |  |  | 1.92 |
Forfeited |  |  | - |  |  |  | - |
Outstanding at June 30, 2023 |  |  | 75,293 |  |  | $ | 1.97 |
Granted |  |  | - |  |  |  | - |
Vested |  |  | (64,696 | ) |  |  | 1.98 |
Forfeited |  |  | - |  |  |  | - |
Outstanding at June 30, 2024 |  |  | 10,597 |  |  | $ | 1.90 |
Schedule of Estimates Fair Value of Each Option Award | The Company estimates the fair value of each option award using the Black-Scholes option-pricing model. The Company used the following assumptions for to estimate the fair value of stock options for the period presented:
|  | Six Months Ended December 31, |
|  | 2024 |  |  | 2023 |
Weighted-average fair value |  | $ | 1.89 |  |  | $ | 2.48 |
Expected volatility |  |  | 113.9% - 122.4 | % |  |  | 104.9% - 106.6 | %
Expected term |  |  | 1.0 years - 5.3 years |  |  |  | 5.0 years - 6.2 years |
Dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Risk-free interest rate |  |  | 3.87% - 4.31 | % |  |  | 3.94% - 4.92 | %
| The Company estimates the fair value of each option award using the Black-Scholes option-pricing model. The Company used the following assumptions for to estimate the fair value of stock options for the period presented:
|  | Year Ended June 30, |
|  | 2024 |  |  | 2023 |
Weighted-average fair value |  | $ | 2.52 |  |  | $ | 2.45 |
Expected volatility |  |  | 105% - 114 | % |  |  | 100% - 134 | %
Expected term |  |  | 5.0 years - 6.2 years |  |  |  | 5.0 years - 7.0 years |
Dividend yield |  |  | 0.00 | % |  |  | 0.00 | %
Risk-free interest rate |  |  | 3.94% - 4.92 | % |  |  | 1.26% - 4.24 | %
Schedule of Stock Option Activity | The following is a schedule summarizing stock option activities for the periods presented:
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (1) |
Outstanding at October 1, 2024 |  |  | 1,056,487 |  |  | $ | 2.42 |  |  | $ | 794,863 |
Granted |  |  | 54,000 |  |  |  | 3.12 |  |  |  |  |
Exercised |  |  | (155,666 | ) |  |  | 2.11 |  |  |  |  |
Expired/forfeited |  |  | - |  |  |  | - |  |  |  |  |
Outstanding at December 31, 2024 |  |  | 954,821 |  |  | $ | 2.51 |  |  | $ | 4,908,085 |
Exercisable at December 31, 2024 |  |  | 665,348 |  |  | $ | 2.44 |  |  | $ | 3,469,609 |
Outstanding at October 1, 2023 |  |  | 995,500 |  |  | $ | 2.33 |  |  | $ | 965,500 |
Granted |  |  | 7,000 |  |  |  | 2.90 |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Expired/forfeited |  |  | (41,375 | ) |  |  | 2.09 |  |  |  |  |
Outstanding at December 31, 2023 |  |  | 961,125 |  |  | $ | 2.35 |  |  | $ | 566,485 |
Exercisable at December 31, 2023 |  |  | 481,560 |  |  | $ | 2.20 |  |  | $ | 350,521 |
(1) | Represents the excess of the fair value on the last day of period (which was $7.65 and $2.90 as of December 31, 2024 and 2023, respectively) over the exercise price, multiplied by the number of options.
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (1) |
Outstanding at July 1, 2024 |  |  | 1,068,000 |  |  | $ | 2.41 |  |  | $ | 1,257,520 |
Granted |  |  | 66,000 |  |  |  | 3.12 |  |  |  |  |
Exercised |  |  | (155,666 | ) |  |  | 2.11 |  |  |  |  |
Expired/forfeited |  |  | (23,959 | ) |  |  | 2.39 |  |  |  |  |
Outstanding at December 31, 2024 |  |  | 954,821 |  |  | $ | 2.51 |  |  | $ | 4,908,085 |
Exercisable at December 31, 2024 |  |  | 665,348 |  |  | $ | 2.44 |  |  | $ | 3,469,609 |
Outstanding at July 1, 2023 |  |  | 1,034,000 |  |  | $ | 2.31 |  |  | $ | 639,775 |
Granted |  |  | 13,500 |  |  |  | 3.11 |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Expired/forfeited |  |  | (86,375 | ) |  |  | 2.04 |  |  |  |  |
Outstanding at December 31, 2023 |  |  | 961,125 |  |  | $ | 2.35 |  |  | $ | 566,485 |
Exercisable at December 31, 2023 |  |  | 481,560 |  |  | $ | 2.20 |  |  | $ | 350,521 |
| The following is a schedule summarizing stock option activities for the periods presented:
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (1) |
Outstanding at July 1, 2023 |  |  | 1,034,000 |  |  | $ | 2.31 |  |  | $ | 639,775 |
Granted |  |  | 120,821 |  |  |  | 3.01 |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Expired/cancelled |  |  | (201,000 | ) |  |  | 2.08 |  |  |  |  |
Outstanding at June 30, 2024 |  |  | 953,821 |  |  | $ | 2.45 |  |  | $ | 1,087,178 |
Exercisable at June 30, 2024 |  |  | 550,116 |  |  | $ | 2.36 |  |  | $ | 673,901 |
(1) | Represents the excess of the fair value on the last day of period (which was $3.59 as of June 30, 2024) over the exercise price, multiplied by the number of options.
|  | Number of Options |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (1) |
Outstanding at July 1, 2022 |  |  | 817,750 |  |  | $ | 2.00 |  |  | $ | - |
Granted |  |  | 471,250 |  |  |  | 2.68 |  |  |  |  |
Exercised |  |  | - |  |  |  | - |  |  |  |  |
Expired/cancelled |  |  | (255,000 | ) |  |  | 2.00 |  |  |  |  |
Outstanding at June 30, 2023 |  |  | 1,034,000 |  |  | $ | 2.31 |  |  | $ | 639,775 |
Exercisable at June 30, 2023 |  |  | 360,060 |  |  | $ | 2.05 |  |  | $ | 309,248 |
(1) | Represents the excess of the fair value on the last day of period (which was $2.90 as of June 30, 2023) over the exercise price, multiplied by the number of options.

X
- References No definition available. + Details
Name: | us-gaap_DisclosureOfCompensationRelatedCostsSharebasedPaymentsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average grant date fair value for restricted stock units that were outstanding at the beginning and end of the year, and the number of restricted stock units that were granted, vested, or forfeited during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationRestrictedStockUnitsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure for stock option plans. Includes, but is not limited to, outstanding awards at beginning and end of year, grants, exercises, forfeitures, and weighted-average grant date fair value. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (c)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (d) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (e) -SubTopic 10 -Topic 718 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 718 -SubTopic 10 -Subparagraph (f)(2) -Name Accounting Standards Codification -Paragraph 2 -Section 50 -Publisher FASB -URI https://asc.fasb.org/1943274/2147480429/718-10-50-2 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration